Morning Market Movers
September 15, 2014 at 09:42 AM EDT
Avanir Pharmaceuticals (NASDAQ: AVNR) shares jumped 47.48% to $9.94 after the company reported positive Phase II trial results for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.